A detailed history of Pfs Investments Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Pfs Investments Inc. holds 16,579 shares of ABT stock, worth $1.89 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,579
Previous 16,555 0.14%
Holding current value
$1.89 Million
Previous $1.74 Million 4.03%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $2,418 - $2,694
24 Added 0.14%
16,579 $1.81 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $129,792 - $152,773
-1,340 Reduced 7.49%
16,555 $1.74 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $139,643 - $163,822
1,469 Added 8.94%
17,895 $1.97 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $53,024 - $61,392
548 Added 3.45%
16,426 $1.59 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $269,158 - $325,326
2,637 Added 19.92%
15,878 $1.73 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $396,675 - $483,720
3,479 Added 35.64%
13,241 $1.57 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $61,577 - $75,398
533 Added 5.78%
9,762 $1.37 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $115,726 - $128,027
992 Added 12.04%
9,229 $1.17 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $108,963 - $128,265
1,030 Added 14.29%
8,237 $986,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $195,585 - $230,429
1,797 Added 33.22%
7,207 $864,000
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $209,265 - $228,039
1,993 Added 58.33%
5,410 $600,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $83,300 - $101,162
909 Added 36.24%
3,417 $372,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $192,037 - $245,784
2,508 New
2,508 $229,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pfs Investments Inc. Portfolio

Follow Pfs Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfs Investments Inc. with notifications on news.